Thus, AML blasts exert T-cell subversion through multiple mechanisms (Figure 2), but a recent longitudinal study underlined the restoration of these CD8+ T-cell dysfunctions after chemotherapy in responder patients [79]. This evidence concerns the gene CD8A and acute myeloid leukemia.